Search

Author/Creator Markova, Denka

1. A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician's choice of therapy in patients with advanced breast cancer and a germline BRCA mutation: EMBRACA subgroups by age. (October 2018)

Authors:
Yerushalmi, Rinat; Eiermann, Wolfgang; Rugo, Hope; Ettl, Johannes; Hurvitz, Sara A.; Gonçalves, Anthony; Miguel, Martin; Markova, Denka; Tudor, Iulia; Blum, Joanne; Hannah, Alison; Litton, Jennifer
Journal:
Breast
Issue:
Volume 41(2018)Supplement 1
Page Start:
S12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Bupropion for the treatment of methamphetamine dependence in non-daily users: A randomized, double-blind, placebo-controlled trial. (1st May 2015)

Authors:
Anderson, Ann L.; Li, Shou-Hua; Markova, Denka; Holmes, Tyson H.; Chiang, Nora; Kahn, Roberta; Campbell, Jan; Dickerson, Daniel L.; Galloway, Gantt P.; Haning, William; Roache, John D.; Stock, Christopher; Elkashef, Ahmed M.
Journal:
Drug and alcohol dependence
Issue:
Volume 150(2015)
Page Start:
170
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗